Northwestern Mutual Wealth Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.86K	Buy	83 +80	+2,667%	+$3.84K	﹤0.01%	3480
2026 Q1	$155	Buy	+3	New	+$153	﹤0.01%	3963
2025 Q3	–	Sell	-122	Closed	-$3.85K	–	4044
2025 Q2	$3.85K	Hold	122	–	–	﹤0.01%	3087
2025 Q1	$4K	Hold	122	–	–	﹤0.01%	3003
2024 Q4	$4.41K	Buy	122 +59	+94%	+$2.08K	﹤0.01%	2983
2024 Q3	$1.96K	Buy	+63	New	+$1.97K	﹤0.01%	3121
2022 Q3	–	Sell	-80	Closed	-$2K	–	3385
2022 Q2	$2K	Buy	+80	New	+$2.29K	﹤0.01%	2949
2021 Q3	–	Sell	-86	Closed	-$3K	–	3210
2021 Q2	$3K	Buy	+86	New	+$2.64K	﹤0.01%	2762
2020 Q2	–	Sell	-80	Closed	-$1K	–	2680
2020 Q1	$1K	Buy	+80	New	+$1.68K	﹤0.01%	2464
2019 Q3	–	Sell	-98	Closed	-$3K	–	2677
2019 Q2	$3K	Buy	98 +53	+118%	+$1.82K	﹤0.01%	2252
2019 Q1	$2K	Buy	+45	New	+$1.67K	﹤0.01%	2341
2017 Q1	–	Sell	-518	Closed	-$13K	–	2374
2016 Q4	$13K	Sell	518 -77	-13%	-$1.72K	﹤0.01%	1519
2016 Q3	$15K	Buy	595 +26	+5%	+$588	﹤0.01%	1365
2016 Q2	$12K	Sell	569 -109	-16%	-$1.93K	﹤0.01%	1315
2016 Q1	$10K	Buy	+678	New	+$8.85K	﹤0.01%	1451

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Northwestern Mutual Wealth Management's SUPN Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its Supernus Pharmaceuticals (SUPN) stake by 2,667% in Q2 2026, buying an estimated $3.84K and bringing the position to 83 shares worth $3.86K. The position accounts for ﹤0.01% of the portfolio, ranked #3480.

Northwestern Mutual Wealth Management first reported a position in SUPN in Q1 2016 and has held it in 15 quarters since. The position peaked at $15K in Q3 2016. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Northwestern Mutual Wealth Management held 83 shares of Supernus Pharmaceuticals worth $3.86K as of Q2 2026.
Northwestern Mutual Wealth Management bought 80 Supernus Pharmaceuticals shares in Q2 2026, an estimated $3.84K.
Supernus Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3480 holding.
Northwestern Mutual Wealth Management first reported a position in Supernus Pharmaceuticals in Q1 2016 and has held it in 15 quarters since.
Northwestern Mutual Wealth Management's Supernus Pharmaceuticals position peaked at $15K in Q3 2016.
334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.